Product Information
HM IBUPROFEN 200 MG SOFTGEL is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0783 per EA under NDC 62011039901. Its NADAC has been published 274 times since Feb 19, 2020.
FDA first approved this application on Jun 21, 2016.
The High Outlier badge above means this manufacturer's average price in the Ibuprofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
62011039901
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA206568FDA Approved
6/21/2016
On Market Since
2/28/2018
Pharmacological Classes
Price Statistics
The NADAC for HM IBUPROFEN 200 MG SOFTGEL has been published 274 times since Feb 19, 2020, and over the history we have for it it has declined 16.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0783 per EA |
|---|---|
| All-time high | $0.1178 (Jul 15, 2020) |
| All-time low | $0.0720 (Mar 23, 2022) |
| Median price | $0.0826 |
| Average price | $0.0852 |
| Largest weekly change | +31.0% (Jun 17, 2020) |
| Weeks tracked | 274 |
| Tracking since | Feb 19, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-0.8%
5Y
-11.4%
All
-16.0%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HM IBUPROFEN 200 MG SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for HM IBUPROFEN 200 MG SOFTGEL, manufactured by Strategic Sourcing Services LLC, is $0.0783 per EA (NDC 62011039901), effective May 14, 2025.
How has the price of HM IBUPROFEN 200 MG SOFTGEL changed over time?
Over the history we have for it, the NADAC for HM IBUPROFEN 200 MG SOFTGEL has declined 16.0%. It has been tracked across 274 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for HM IBUPROFEN 200 MG SOFTGEL?
Since Feb 19, 2020, the NADAC for HM IBUPROFEN 200 MG SOFTGEL has ranged from a low of $0.0720 (Mar 23, 2022) to a high of $0.1178 (Jul 15, 2020), with a median of $0.0826 per EA.
Are there cheaper alternatives to HM IBUPROFEN 200 MG SOFTGEL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 200 MG SOFTGEL, is $0.0780 per EA — about 0% below HM IBUPROFEN 200 MG SOFTGEL.
Who manufactures HM IBUPROFEN 200 MG SOFTGEL?
HM IBUPROFEN 200 MG SOFTGEL (NDC 62011039901) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.